Coronary Artery Stenosis Clinical Trial
Official title:
Comparison of Fractional Flow Reserve and Minimal Luminal Area by Intravascular Ultrasound in Evaluating Intermediate Coronary Artery Stenosis in Each Coronary Artery
This study will evaluate the relationship of Fractional Flow Reserve (FFR) and Minimal Lumen Area (MLA) by IntraVascular UltraSound (IVUS) by comparing the results of the both tests which is done as a part of the cardiac catheterization.
Invasive X-ray coronary angiography remains the "reference standard" for the evaluation of
coronary artery stenoses. Recently, intravascular ultrasound (IVUS) has been introduced as
an invasive method for the evaluation of coronary artery stenoses and has been shown to be
highly accurate in stenosis detection when compared to X-ray angiography. While invasive
X-ray angiography and IVUS evaluate morphological features of coronary arterial plaques,
fractional flow reserve (FFR) is an invasive measure of the hemodynamic significance of a
stenosis obtained in the catheterization laboratory by measuring changes in intracoronary
arterial pressure before and after maximal vasodilation induced by intravenous adenosine. An
FFR value less than 0.75 has been shown to predict ischemia in vascular beds distal to the
stenosis by radionuclide perfusion modalities and has been shown to be associated with worse
outcomes. Therefore, FFR is considered to be an invasive hemodynamic "reference standard"
for the evaluation of the hemodynamic significance of coronary arterial stenoses. While IVUS
can provide additional morphological information in intermediate stenoses, it can not
provide further functional information.
We are currently conducting investigation in the validation of IVUS against FFR in
intermediate coronary artery stenoses in each coronary arteries. However, the difference of
the values of IVUS data in each coronary artery, eg. left anterior descending artery or
right coronary artery, has not been validated against invasive hemodynamic measurements of
fractional flow reserve in patients with intermediate stenoses by invasive X-ray
angiography. We hypothesize that IVUS-derived measurements are interpreted differently in
each coronary arteries in the diagnosis of hemodynamically significant coronary artery
stenoses, using FFR as the reference standard in patients with coronary artery stenoses 40%<
and <70%.
;
Endpoint Classification: Bio-equivalence Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05133843 -
Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis
|
N/A | |
| Completed |
NCT01205776 -
EXCEL Clinical Trial
|
N/A | |
| Completed |
NCT00739466 -
Biorest Liposomal Alendronate With Stenting sTudy (BLAST)
|
Phase 2 | |
| Completed |
NCT01332591 -
Multivessel Disease Diagnosed at the Time of PPCI for STEMI: Complete Revascularization Versus Conservative Strategy.
|
N/A | |
| Completed |
NCT01182428 -
XIENCE V: SPIRIT WOMEN Sub-study
|
Phase 4 | |
| Completed |
NCT00531011 -
EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease
|
Phase 4 | |
| Completed |
NCT01310309 -
EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease
|
Phase 4 | |
| Not yet recruiting |
NCT06052670 -
Functional Diagnostic Accuracy of Ultrasonic Flow Ratio in Assessment of Coronary Artery Lesions
|
||
| Completed |
NCT05509296 -
Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease
|
N/A | |
| Not yet recruiting |
NCT05393882 -
Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency
|
||
| Recruiting |
NCT06397820 -
Relation Between AI-QCA and Cardiac PET
|
||
| Active, not recruiting |
NCT01960504 -
First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II)
|
N/A | |
| Completed |
NCT01721096 -
XIENCE PRIME Japan Post-Marketing Surveillance (PMS)
|
||
| Active, not recruiting |
NCT01342822 -
Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization
|
Phase 4 | |
| Completed |
NCT01205789 -
EXCEL Clinical Trial (Universal Registry)
|
N/A | |
| Recruiting |
NCT05532605 -
Effects of Mindfulness Based Therapy on Illness and Depression in Cardiac Rehab Phase-i
|
N/A | |
| Completed |
NCT02066623 -
Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffold
|
||
| Not yet recruiting |
NCT02946320 -
Optimal Predilatation Technique for BVS Implantation
|
Phase 3 | |
| Terminated |
NCT01136915 -
Kidney Damage In Patients With Severe Fall In eGFR
|
Phase 4 | |
| Completed |
NCT01249027 -
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
|